跳至主要内容
临床试验/CTRI/2013/10/004077
CTRI/2013/10/004077招募中未知

Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.

Roche Products India Pvt Ltd0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Inclusion Criteria
  • Patients must meet the following criteria for study entry:
  • · Adult male or female patients of age >= 18years.
  • · Diagnosed case of NSCLC with availability of representative tumor specimen for
  • genetic analysis, from the biopsy sample.
  • · Written informed consent

排除标准

  • Patients who meet the following criteria will be excluded from study:
  • · Patients, who in the opinion of the investigator, are unable to comply with study
  • requirements

研究者

相似试验